Kura Oncology Inc.
KURA | NASDAQ
$11.78
+$0.18 (+1.55%)
Sep 22, 2026, 10:51 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -3.27 | -4.31 | -6.91 | -6.11 | -7.11 | -19.33 |
PEG Ratio | -0.06 | 1.49 | -2.81 | -2.01 | -0.43 | -1.62 |
PS Ratio | 13.50 | 13.93 | n/a | n/a | n/a | n/a |
PB Ratio | 5.23 | 1.81 | 2.65 | 1.98 | 1.83 | 2.84 |
P/FCF Ratio | -12.89 | 5.61 | -8.42 | -7.51 | -8.79 | -24.08 |
P/OCF Ratio | -14.22 | 5.59 | -8.44 | -7.55 | -8.88 | -24.82 |
OCF/S Ratio | -94.93 | 249.28 | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.12 | 0.04 | 0.04 | 0.03 | 0.01 | 0.02 |
Quick Ratio | 6.05 | 9.46 | 12.26 | 18.56 | 23.26 | 24.49 |
Current Ratio | 6.06 | 9.46 | 12.26 | 18.56 | 23.26 | 24.49 |
Asset Turnover | 0.09 | 0.07 | n/a | n/a | n/a | n/a |
Interest Coverage | -200.81 | -119.33 | -107.04 | -610.76 | -317.05 | -158.99 |
Return on Equity | -160.03% | -42.06% | -38.42% | -32.32% | -25.75% | -14.67% |
Return on Assets | -37.74% | -22.89% | -34% | -29.77% | -24.43% | -13.85% |
Return on Invested Capital | -48.76% | -28.17% | -39.94% | -32.18% | -25.54% | -14.67% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 99.92% | 100% | n/a | n/a | n/a | n/a |
Net Profit Margin | -412.95% | -322.89% | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -412.51% | -319.15% | n/a | n/a | n/a | n/a |
Operating Profit Margin | -449.94% | -358.55% | n/a | n/a | n/a | n/a |
FCF Margin | -104.76% | 248.40% | n/a | n/a | n/a | n/a |
EBITDA Margin | -408.74% | -314.57% | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove KURA